Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Schering-Plough |
---|---|
Information provided by: | Schering-Plough |
ClinicalTrials.gov Identifier: | NCT00795522 |
This open-label study is being conducted to determine the effect of DL treatment for CIU on symptom and disease severity, quality of life, daytime functioning, and quality of sleep.
Condition | Intervention | Phase |
---|---|---|
Urticaria |
Drug: Desloratadine |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria |
Enrollment: | 51 |
Study Start Date: | July 2003 |
Study Completion Date: | March 2005 |
Primary Completion Date: | February 2005 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Arm 1: Experimental
Desloratadine
|
Drug: Desloratadine
Subjects will receive DL 5 mg daily for 28 days. Each active DL tablet contains 5 mg of desloratadine
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Schering-Plough ( Head, Clinical Trials Registry & Results Disclosure Group ) |
Study ID Numbers: | P02540 |
Study First Received: | November 19, 2008 |
Last Updated: | November 20, 2008 |
ClinicalTrials.gov Identifier: | NCT00795522 |
Health Authority: | Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica |
Hypersensitivity Skin Diseases Hypersensitivity, Immediate Histamine phosphate |
Quality of Life Urticaria Desloratadine Histamine |
Neurotransmitter Agents Skin Diseases, Vascular Histamine Antagonists Molecular Mechanisms of Pharmacological Action Cholinergic Antagonists Immune System Diseases |
Physiological Effects of Drugs Histamine Agents Histamine H1 Antagonists Histamine H1 Antagonists, Non-Sedating Cholinergic Agents Pharmacologic Actions |